Sequential™ Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing and Next-Generation Skin Health Ingredients

Sequential, a leader in genomic testing from non-invasive human clinical samples, today announced the successful close of its first equity round, securing $3.5 million.

Sequential Raises $3.5M to Build AI-Powered Discovery Platform for Multi-Omic Testing and Next-Generation Skin Health Ingredients

Sequential, a leader in genomic testing from non-invasive human clinical samples, today announced the successful close of its first equity ...
telecom.economictimes.indiatimes

Allowing ‘parallel testing’ for electronics hardware to reduce time to market, improve EoDB: MAIT

NEW DELHI: The Centre’s move to allow parallel testing instead of the presently prevalent sequential testing for electronics hardware products will reduce time-to-market and improve the ease of doing ...
ascopubs.org

Cost-Effectiveness of Parallel Versus Sequential Testing of Genetic Aberrations for Stage IV Non–Small-Cell Lung Cancer in the Netherlands

Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2–Activating Mutations: Results From the National Cancer Institute–Molecular Analysis for Therapy Choice ...
Finanznachrichten

Sequential Skin Ltd: Sequential Skin debuts Sequential Bio - the world's first in-vivo microbiome testing solution for skin, hair, and personal product industries.

LONDON, NEW YORK and SINGAPORE, March 3, 2022 /PRNewswire/ -- Sequential Skin Ltd, a leading microbiome company today announced the debut of Sequential Bio - a novel "in-vivo" microbiome testing ...